Table of Contents Author Guidelines Submit a Manuscript
Table of Contents Alerts

To receive news and publication updates for Case Reports in Hematology, enter your email address in the box below.

Case Reports in Hematology
Volume 2016, Article ID 6165172, 4 pages
http://dx.doi.org/10.1155/2016/6165172
Case Report

Minimally Invasive Diagnosis of Secondary Intracranial Lymphoma

A. P. McClement,1 G. M. Healy,2 C. E. Redmond,2 E. Stocker,3 G. Connaghan,3 S. J. Skehan,2 and R. P. Killeen2

1School of Medicine, University College Dublin, Belfield, Dublin 4, D04 V1W8, Ireland
2Department of Radiology, St. Vincent’s University Hospital, Elm Park, Dublin 4, D04T6F4, Ireland
3Department of Haematology, St. Vincent’s University Hospital, Elm Park, Dublin 4, D04T6F4, Ireland

Received 30 July 2016; Revised 4 November 2016; Accepted 9 November 2016

Academic Editor: Stephen Langabeer

Copyright © 2016 A. P. McClement et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Rosenwald, G. Wright, W. C. Chan et al., “The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma,” The New England Journal of Medicine, vol. 346, no. 25, pp. 1937–1947, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Pfreundschuh, L. Trümper, A. Österborg et al., “CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group,” The Lancet Oncology, vol. 7, no. 5, pp. 379–391, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. W. M. Tai, J. Chung, P. L. Tang et al., “Central nervous system (CNS) relapse in diffuse large B cell lymphoma (DLBCL): pre- and post-rituximab,” Annals of Hematology, vol. 90, no. 7, pp. 809–818, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Kridel and P.-Y. Dietrich, “Prevention of CNS relapse in diffuse large B-cell lymphoma,” The Lancet Oncology, vol. 12, no. 13, pp. 1258–1266, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. F. Longo, G. De Maria, P. Esposito, and L. Califano, “Primary non-Hodgkin's lymphoma of the mandible. Report of a case,” International Journal of Oral and Maxillofacial Surgery, vol. 33, no. 8, pp. 801–803, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Dinakar, L. Priya, and S. Reddy, “Primary non-Hodgkin's lymphoma of the mandible,” Journal of Oral and Maxillofacial Pathology: JOMFP, vol. 14, no. 2, pp. 73–76, 2010. View at Publisher · View at Google Scholar
  7. L. Djavanmardi, N. Oprean, A. Alantar, K. Bousetta, and G. Princ, “Malignant non-Hodgkin's lymphoma (NHL) of the jaws: a review of 16 cases,” Journal of Cranio-Maxillofacial Surgery, vol. 36, no. 7, pp. 410–414, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. D. G. Panduric, T. Kuna, and D. Katanec, “Pain after tooth extraction masking primary extranodal non-hodgkin's lymphoma of the oral cavity/Primarni ekstranodularni Non-Hodgkinov limfom usne supljine prikriven boli nakon vadenja zuba,” Acta Stomatologica Croatica, vol. 41, no. 4, p. 366, 2007. View at Google Scholar
  9. S. J. Parrington and A. Punnia-Moorthy, “Primary non-Hodgkin's lymphoma of the mandible presenting following tooth extraction,” British Dental Journal, vol. 187, no. 9, pp. 468–470, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Bertolotto, G. Cecchini, C. Martinoli, R. Perrone, and G. Garlaschi, “Primary lymphoma of the mandible with diffuse widening of the mandibular canal: report of a case,” European Radiology, vol. 6, no. 5, pp. 637–639, 1996. View at Google Scholar · View at Scopus
  11. T. Yamada, Y. Kitagawa, T. Ogasawara, S. Yamamoto, Y. Ishii, and Y. Urasaki, “Enlargement of mandibular canal without hypesthesia caused by extranodal non-Hodgkin's lymphoma: a case report,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, vol. 89, no. 3, pp. 388–392, 2000. View at Publisher · View at Google Scholar
  12. Y. N. Mojaver, M. Sahebjamie, F. Tirgary, M. Eslami, and G. Rezvani, “Enlargement of mandibular canal with tongue paresthesia caused by extranodal B-cell Lymphoma: a case report,” Oral Oncology Extra, vol. 41, no. 5, pp. 97–99, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. V. M. Vartiainen, M. Siponen, T. Salo, J. Rosberg, and M. Apaja-Sarkkinen, “Widening of the inferior alveolar canal: a case report with atypical lymphocytic infiltration of the nerve,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology, vol. 106, no. 4, pp. e35–e39, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Afshar-Oromieh, C. Kratochwil, U. Haberkorn, and F. L. Giesel, “Importance of PET/CT in lymphoma diagnostics,” Der Radiologe, vol. 52, no. 4, pp. 338–346, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. F. M. Paes, A. D. Singer, A. N. Checkver, R. A. Palmquist, G. De La Vega, and C. Sidani, “Perineural spread in head and neck malignancies: clinical significance and evaluation with 18F-FDG PET/CT,” Radiographics, vol. 33, no. 6, pp. 1717–1736, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. M. D. D'Souza, A. Jaimini, A. Bansal et al., “FDG-PET/CT in lymphoma,” Indian Journal of Radiology & Imaging, vol. 23, no. 4, pp. 354–365, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. B. E. Akkas and G. U. Vural, “The incidence of secondary central nervous system involvement in patients with non-Hodgkin's lymphoma as detected by 1818F-FDG PET/CT,” Nuclear Medicine Communications, vol. 34, no. 1, pp. 50–56, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. Q. A. Hill and R. G. Owen, “CNS prophylaxis in lymphoma: who to target and what therapy to use,” Blood Reviews, vol. 20, no. 6, pp. 319–332, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Fest, A. Rozenbaum, F. Cattin, R. Chambers, J.-P. Carbillet, and J.-F. Bonneville, “Neuroblastoma-like epidural localization in non-Hodgkin's lymphoma,” Neuroradiology, vol. 30, no. 6, pp. 569–570, 1988. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Maroldi, C. Ambrosi, and D. Farina, “Metastatic disease of the brain: extra-axial metastases (skull, dura, leptomeningeal) and tumour spread,” European Radiology, vol. 15, no. 3, pp. 617–626, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. L. M. DeAngelis and D. Boutros, “Leptomeningeal metastasis,” Cancer Investigation, vol. 23, no. 2, pp. 145–154, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. I. S. Haldorsen, A. Espeland, and E.-M. Larsson, “Central nervous system lymphoma: characteristic findings on traditional and advanced imaging,” American Journal of Neuroradiology, vol. 32, no. 6, pp. 984–992, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. H. Malone, J. Yang, D. L. Hershman, J. D. Wright, J. N. Bruce, and A. I. Neugut, “Complications following stereotactic needle biopsy of intracranial tumors,” World Neurosurgery, vol. 84, no. 4, pp. 1084–1089, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Malikova, R. Liscak, I. Latnerova, K. Guseynova, M. Syrucek, and R. Pytlik, “Complications of MRI-guided stereotactic biopsy of brain lymphoma,” Neuro Endocrinology Letters, vol. 35, no. 7, pp. 613–618, 2014. View at Google Scholar
  25. R. Schroers, A. Baraniskin, C. Heute et al., “Diagnosis of leptomeningeal disease in diffuse large B-cell lymphomas of the central nervous system by flow cytometry and cytopathology,” European Journal of Haematology, vol. 85, no. 6, pp. 520–528, 2010. View at Publisher · View at Google Scholar · View at Scopus